122 related articles for article (PubMed ID: 2035723)
1. Elevation of plasma concentrations of haloperidol after the addition of fluoxetine.
Goff DC; Midha KK; Brotman AW; Waites M; Baldessarini RJ
Am J Psychiatry; 1991 Jun; 148(6):790-2. PubMed ID: 2035723
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate.
Centorrino F; Baldessarini RJ; Kando J; Frankenburg FR; Volpicelli SA; Puopolo PR; Flood JG
Am J Psychiatry; 1994 Jan; 151(1):123-5. PubMed ID: 8267110
[TBL] [Abstract][Full Text] [Related]
3. [Pharmaco-clinical correlations during fluoxetine administration in patients with depressive schizophrenia treated with haloperidol decanoate].
Viala A; Aymard N; Leyris A; Caroli F
Therapie; 1996; 51(1):19-25. PubMed ID: 8762216
[TBL] [Abstract][Full Text] [Related]
4. Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data.
Potkin SG; Shen YC; Zhou DF; Pardes H; Shu L; Phelps B; Poland R
Psychopharmacol Bull; 1985; 21(1):59-61. PubMed ID: 3983339
[No Abstract] [Full Text] [Related]
5. Fluoxetine augmentation of haloperidol in chronic schizophrenia.
Shim JC; Kelly DL; Kim YH; Yoon YR; Park JH; Shin JG; Conley RR
J Clin Psychopharmacol; 2003 Oct; 23(5):520-2. PubMed ID: 14520132
[No Abstract] [Full Text] [Related]
6. Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.
Volavka J; Cooper TB; Meisner M; Bitter I; Czobor P; Jaeger J
Psychopharmacol Bull; 1990; 26(1):13-7. PubMed ID: 2371368
[TBL] [Abstract][Full Text] [Related]
7. Psychotolysis with haloperidol. Rapid control of the acutely disturbed psychotic patient.
Carter RG
Dis Nerv Syst; 1977 Apr; 38(4):237-9. PubMed ID: 849701
[No Abstract] [Full Text] [Related]
8. Effects of haloperidol on human plasma magnesium.
Jabotinsky-Rubin K; Durst R; Levitin LA; Moscovich DG; Silver H; Lerner J; Van Praag H; Gardner EL
J Psychiatr Res; 1993; 27(2):155-9. PubMed ID: 8366466
[TBL] [Abstract][Full Text] [Related]
9. Plasma haloperidol levels and clinical response: confounding variables.
Mavroidis ML; Garver DL; Kanter DR; Hirschowitz J
Psychopharmacol Bull; 1985; 21(1):62-5. PubMed ID: 3983340
[No Abstract] [Full Text] [Related]
10. Combination therapy with haloperidol and orphenadrine in schizophrenia. A clinical and pharmacokinetic study.
Altamura AC; Buccio M; Colombo G; Terzi A; Cazzullo CL
Encephale; 1986; 12(1):31-6. PubMed ID: 3698889
[TBL] [Abstract][Full Text] [Related]
11. Interaction between fluoxetine and haloperidol: pharmacokinetic and clinical implications.
Avenoso A; Spinà E; Campo G; Facciolă G; Ferlito M; Zuccaro P; Perucca E; Caputi AP
Pharmacol Res; 1997 Apr; 35(4):335-9. PubMed ID: 9264051
[TBL] [Abstract][Full Text] [Related]
12. [Standard and high doses of haloperidol. Clinical, pharmacokinetic and pharmacodynamic aspects].
Schilkrut R; Haverbeck C; Duran E; Delgado S; Kohen P; Birkner R; Katz I
Acta Psiquiatr Psicol Am Lat; 1981; 27(4-5):315-24. PubMed ID: 7348089
[TBL] [Abstract][Full Text] [Related]
13. Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine.
Kapur S; Roy P; Daskalakis J; Remington G; Zipursky R
Am J Psychiatry; 2001 Feb; 158(2):311-4. PubMed ID: 11156818
[TBL] [Abstract][Full Text] [Related]
14. Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?
Arana GW; Goff DC; Friedman H; Ornsteen M; Greenblatt DJ; Black B; Shader RI
Am J Psychiatry; 1986 May; 143(5):650-1. PubMed ID: 3963258
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of a new dibenzo-epine neuroleptic compared with haloperidol. Results of an open and crossover study.
Mann K; Bartels M; Gärtner HJ; Schied HW; Wagner W; Heimann H
Pharmacopsychiatry; 1987 Jul; 20(4):155-9. PubMed ID: 2886997
[TBL] [Abstract][Full Text] [Related]
16. Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia.
Rao VA; Bishop M; Coppen A
Br J Psychiatry; 1980 Dec; 137():518-21. PubMed ID: 7214106
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of fluoxetine on plasma clozapine concentrations.
Eggert AE; Crismon ML; Dorson PG
J Clin Psychiatry; 1994 Oct; 55(10):454-5. PubMed ID: 7961525
[No Abstract] [Full Text] [Related]
18. [Pharmacokinetic of haloperidol decanoate in psychotic patients (author's transl)].
Parent M; Toussaint C; Driesens F; Gelders Y
Acta Psychiatr Belg; 1981; 81(4):399-406. PubMed ID: 7331843
[No Abstract] [Full Text] [Related]
19. Plasma haloperidol levels drawn at neuroleptic threshold doses: a pilot study.
McEvoy JP; Stiller RL; Farr R
J Clin Psychopharmacol; 1986 Jun; 6(3):133-8. PubMed ID: 3711363
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of extrapyramidal side effects of haloperidol through the joint use of imipramine-type drugs.
Butterworth AT
Psychosomatics; 1972; 13(5):328-32. PubMed ID: 4671924
[No Abstract] [Full Text] [Related]
[Next] [New Search]
